Merck KGaA (OTCMKTS:MKKGY) Short Interest Update

Merck KGaA (OTCMKTS:MKKGY) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totaling 100,145 shares, a decrease of 58.6% from the December 15th total of 241,637 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 142,816 shares, the days-to-cover ratio is presently 0.7 days. Based on an average trading volume of 142,816 shares, the days-to-cover ratio is presently 0.7 days. Currently, 0.0% of the shares of the company are sold short.

Merck KGaA Trading Up 0.9%

Shares of Merck KGaA stock opened at $30.03 on Friday. The stock has a market capitalization of $19.41 billion, a P/E ratio of 11.96, a P/E/G ratio of 6.06 and a beta of 0.95. Merck KGaA has a 52-week low of $24.32 and a 52-week high of $31.80. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.97 and a current ratio of 1.49. The stock’s 50-day simple moving average is $27.89 and its 200 day simple moving average is $26.68.

Merck KGaA (OTCMKTS:MKKGY) last issued its earnings results on Thursday, November 13th. The company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.27. The firm had revenue of $6.17 billion during the quarter, compared to analyst estimates of $6.08 billion. Merck KGaA had a net margin of 13.92% and a return on equity of 10.07%. As a group, research analysts anticipate that Merck KGaA will post 1.87 EPS for the current year.

About Merck KGaA

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.